Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality
暂无分享,去创建一个
Jonathan W Haft | F. Pagani | J. Haft | T. Koelling | K. Aaronson | D. Naftel | J. Matthews | Francis D Pagani | Keith D Aaronson | David C Naftel | Todd M Koelling | Jennifer C Matthews
[1] D. McKenna,et al. HLA alloimmunization in patients requiring ventricular assist device support. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] S. Russell,et al. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. , 2007, The Annals of thoracic surgery.
[3] R. Kormos,et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] G. Hicks,et al. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. , 1992, The Journal of thoracic and cardiovascular surgery.
[5] D. Goldstein,et al. Left ventricular assist devices and bleeding: adding insult to injury. , 2003, The Annals of thoracic surgery.
[6] Robert L. Kormos,et al. Mechanical Circulatory Support device database of the International Society for Heart and Lung Transplantation: first annual report--2003. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[7] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[8] Chris A Rogers,et al. Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.
[9] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[10] T. Therneau,et al. Risk factors for mortality after surgery in patients with cirrhosis. , 2007, Gastroenterology.
[11] J. Connor,et al. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[12] M C Oz,et al. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] J. Hentz,et al. A Comparison of Transfusion Requirements Between Living Donation and Cadaveric Donation Liver Transplantation: Relationship to Model of End-Stage Liver Disease Score and Baseline Coagulation Status , 2005, Anesthesia and analgesia.
[14] M. Deng,et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation , 2003, Current opinion in cardiology.
[15] R. Steadman,et al. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[16] M. Oz,et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. , 1995, The Annals of thoracic surgery.
[17] T M Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.
[18] D. Hearse,et al. Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. , 1993, The Journal of thoracic and cardiovascular surgery.
[19] R. Kormos,et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: Third Annual Report—2005⁎ ⁎All figures and tables from this report, and a more comprehensive set of ISHLT registry slides are available at www.ishlt.org/registries/ , 2005 .
[20] N. Heaton,et al. Change in model for end‐stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation , 2006, Transplant international : official journal of the European Society for Organ Transplantation.
[21] A. Befeler,et al. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. , 2005, Archives of surgery.
[22] N G Smedira,et al. Factors influencing HLA sensitization in implantable LVAD recipients. , 1997, The Annals of thoracic surgery.
[23] R. Adams,et al. Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis , 2005, Annals of surgery.
[24] A. Pavie,et al. Preventing, minimizing, and managing postoperative bleeding. , 1999, The Annals of thoracic surgery.